Publication
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized Phase III trial SAKK 22/99
Journal Paper/Review - Dec 19, 2016
Pagani O, Rabaglio M, Aebi S, Ribi K, Rochlitz C, Rothgiesser K, Thürlimann Beat, Moos R von, Zaman K, Goldhirsch A, Pestalozzi B, Munzone E, Klingbiel D, Ruhstaller Thomas, Nolé F, Eppenberger S, Oehlschlegel C, Bernhard J, Brauchli P, Hess Dagmar, Mamot C
Pagani, O
21
0
Klingbiel, D
7
0
Ruhstaller, Thomas
83
24
Nolé, F
5
0
Eppenberger, S
2
0
Oehlschlegel, C
1
0
Bernhard, J
23
0
Brauchli, P
8
0
Hess, Dagmar
Medizinische Onkologie und Hämatologie · Dept. I
29
18
Mamot, C
2
0
Munzone, E
3
0
Pestalozzi, B
6
0
Rabaglio, M
5
0
Aebi, S
13
0
Ribi, K
10
0
Rochlitz, C
5
0
Rothgiesser, K
1
0
Thürlimann, Beat
259
14
Moos, R von
2
0
Zaman, K
5
0